Nalaganje...
Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family, and GLP-1 receptor agonists (RAs) have been introduced as a new class of antidiabetic medications in the past decade. The benefits of GLP-1 RAs are derived from their pleiotropic effects, which include glucose-dependent...
Shranjeno v:
| izdano v: | Endocrinol Metab (Seoul) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Korean Endocrine Society
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923410/ https://ncbi.nlm.nih.gov/pubmed/27118277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2016.31.2.258 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|